| Neurocrine Biosciences News (2003-2004) |
 |
| Monday, December 1, 2008 |
| SAN DIEGO--- San Diego Science Festival Receives More than $500K in Generous Contributions from Area's Leading Biotechnology and Technology Firms; Over 500 Events are Scheduled for this Free Event Posted 9:15 AM PST |
| |
| Thursday, November 20, 2008 |
| Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference Posted 3:50 PM PST |
| |
| Monday, September 22, 2008 |
| Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference Posted 4:44 PM PST |
| |
| Wednesday, September 3, 2008 |
| Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis Posted 3:04 PM PST |
| |
| Tuesday, September 2, 2008 |
| Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis Posted 5:34 PM PST |
| |
| Monday, August 25, 2008 |
| Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference Posted 4:12 PM PST |
| |
| Tuesday, June 17, 2008 |
| Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis Posted 10:14 AM PST |
| |
| Monday, May 12, 2008 |
| Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference Posted 5:00 PM PST |
| |
| Monday, March 10, 2008 |
| SAN DIEGO--- OREXIGEN Therapeutics Appoints Carol Baum as Vice President of Commercialization Posted 3:54 PM PST |
| |
| Monday, January 14, 2008 |
| SAN DIEGO--- Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer Posted 4:15 PM PST |
| |
| Thursday, December 6, 2007 |
| SAN DIEGO-- Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets Posted 5:28 PM PST |
| |
| Monday, November 26, 2007 |
| Neurocrine Biosciences to Present at the 19th Annual Piper Jaffray Health Care Conference Posted 7:33 AM PST |
| |
| Monday, November 5, 2007 |
| Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference Posted 3:35 PM PST |
| |
| Monday, September 24, 2007 |
| Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference Posted 2:30 PM PST |
| |
| Monday, September 17, 2007 |
| Neurocrine Biosciences to Present at the A.G. Edward's Annual Emerging Growth Conference Posted 4:59 PM PST |
| |
| Monday, September 10, 2007 |
| Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference Posted 2:07 PM PST |
| |
| Thursday, August 30, 2007 |
| Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference Posted 3:30 PM PST |
| |
| Tuesday, August 21, 2007 |
| Neurocrine Announces PDUFA Action Date of December 12, 2007 for Indiplon Capsules Posted 2:39 PM PST |
| |
| Friday, June 15, 2007 |
| CARLSBAD--- Ardea Biosciences, Inc. Expands its Board of Directors Posted 6:12 AM PST |
| |
| Tuesday, June 12, 2007 |
| Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules Posted 4:57 PM PST |
| |
| Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia Posted 8:35 AM PST |
| |
| Friday, May 4, 2007 |
| Neurocrine Biosciences Reports First Quarter 2007 Results Posted 4:52 PM PST |
| |
| Tuesday, February 20, 2007 |
| SAN DIEGO--- Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors Posted 4:37 PM PST |
| |
| SAN DIEGO--- Sequenom Names Financial Veteran Paul W. Hawran Chief Financial Officer Posted 6:31 AM PST |
| |
| Wednesday, January 24, 2007 |
| Neurocrine Biosciences Receives Award From Michael J. Fox Foundation for A2A Research in Parkinson's Disease Posted 10:12 AM PST |
| |
| Monday, January 22, 2007 |
| Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007 Posted 3:40 PM PST |
| |
| Monday, January 8, 2007 |
| Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis Posted 8:03 AM PST |
| |
| Thursday, December 21, 2006 |
| SAN DIEGO--- Neurocrine Announces Organizational Changes Posted 5:30 PM PST |
| |
| Wednesday, December 20, 2006 |
| Neurocrine Biosciences Announces Initiation of Phase II Clinical Trials With CRF1 Antagonist for Anxiety and IBS Posted 9:17 AM PST |
| |
| Thursday, November 2, 2006 |
| Neurocrine Biosciences Reports Third Quarter 2006 Results Posted 4:41 PM PST |
| |
| Wednesday, September 27, 2006 |
| Neurocrine Announces Employee Stock Option Exchange Tender Offer Accepted Posted 3:53 PM PST |
| |
| Tuesday, September 19, 2006 |
| SAN DIEGO--- Neurocrine Announces Organizational Changes; New COO and other changes Posted 3:45 PM PST |
| |
| Friday, September 15, 2006 |
| Kintera Tops Deloitte's San Diego Technology Fast 50 Ranking of Fastest-Growing Companies, With 14,159 Percent Revenue Growth Over Five Years Posted 3:58 PM PST |
| |
| Friday, August 25, 2006 |
| SAN DIEGO--- Paul W. Hawran Named to Sequenom Board of Directors Posted 4:32 PM PST |
| |
| Neurocrine Announces Employee Stock Option Exchange Program Posted 4:31 PM PST |
| |
| Thursday, August 10, 2006 |
| Halozyme Therapeutics Reports Second Quarter 2006 Financial Results Posted 7:50 AM PST |
| |
| Monday, August 7, 2006 |
| Neurocrine Announces San Diego Campus Restructuring Posted 4:40 PM PST |
| |
| Wednesday, July 26, 2006 |
| Halozyme Therapeutics Names Robert Little Chief Commercial Officer Posted 8:49 AM PST |
| |
| Neurocrine Announces the Release of the Sales Force Posted 1:18 PM PST |
| |
| Monday, July 17, 2006 |
| Neurocrine Biosciences Reports Second Quarter 2006 Results Posted 3:11 PM PST |
| |
| Thursday, June 22, 2006 |
| Neurocrine and Pfizer Terminate Collaboration Agreement for Indiplon Posted 3:37 PM PST |
| |
| Thursday, June 15, 2006 |
| Neurocrine Completes Review of Indiplon Action Letters Posted 3:33 PM PST |
| |
| Tuesday, May 16, 2006 |
| Neurocrine Receives Approvable Letter for indiplon Capsules and Non-Approvable for indiplon Tablets for the Treatment of Insomnia Posted 7:22 AM PST |
| |
| Thursday, April 27, 2006 |
| Neurocrine Biosciences Announces Positive Phase II Results With Its Orally Active GnRH Receptor Antagonist in Endometriosis Posted 4:33 PM PST |
| |
| Monday, April 24, 2006 |
| Neurocrine Biosciences Reports First Quarter 2006 Results Posted 3:59 PM PST |
| |
| Thursday, April 6, 2006 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2006 Financial Results Posted 5:34 PM PST |
| |
| Wednesday, April 5, 2006 |
| Neurocrine Announces Peer-Reviewed Publication of Indiplon Mechanism of Action Posted 8:48 AM PST |
| |
| Wednesday, March 8, 2006 |
| Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis Posted 7:51 AM PST |
| |
| Tuesday, March 7, 2006 |
| SAN DIEGO--- Ambit Biosciences Adds Kinase Experts to Scientific Advisory Board and Expands Board of Directors Posted 8:41 AM PST |
| |
| Monday, January 23, 2006 |
| Neurocrine Biosciences Reports Fourth Quarter and Year-End 2005 Results Posted 3:39 PM PST |
| |
| Tuesday, January 10, 2006 |
| Neurocrine Provides Update of Food and Drug Administration's Review of Indiplon Posted 2:32 PM PST |
| |
| Monday, December 19, 2005 |
| Neurocrine Biosciences Announces Positive Phase II Safety and Efficacy Results With Urocortin 2 for Congestive Heart Failure Posted 8:49 AM PST |
| |
| Wednesday, December 7, 2005 |
| SAN DIEGO--- Neurocrine Biosciences Announces the Appointment of Adrian Adams to the Board of Directors Posted 2:29 PM PST |
| |
| Tuesday, November 1, 2005 |
| SAN DIEGO--- Neurocrine Biosciences Announces Appointment of Senior Vice President of Clinical Development Posted 9:11 AM PST |
| |
| Monday, October 24, 2005 |
| Neurocrine Biosciences Reports Third Quarter 2005 Results Posted 5:33 PM PST |
| |
| Monday, October 10, 2005 |
| Neurocrine Biosciences Announces Conference Call for Third Quarter 2005 Financial Results Posted 5:26 PM PST |
| |
| Tuesday, September 6, 2005 |
| Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Tailwinds Conference Posted 5:01 PM PST |
| |
| Tuesday, July 26, 2005 |
| Neurocrine Announces Acceptance of New Drug Application for Indiplon Tablets Posted 9:30 AM PST |
| |
| Tuesday, July 12, 2005 |
| Iconix Announces Chemogenomic Profiling Agreement With Neurocrine Biosciences, Inc. Posted 9:12 AM PST |
| |
| Friday, June 17, 2005 |
| Biosciences Granted New Patent for Indiplon Posted 9:27 AM PST |
| |
| Tuesday, June 14, 2005 |
| Neurocrine Announces Acceptance of New Drug Application for Indiplon Capsules Posted 8:46 AM PST |
| |
| Thursday, May 26, 2005 |
| Neurocrine Announces Submission of New Drug Application for Indiplon Tablets Posted 5:53 PM PST |
| |
| Thursday, April 28, 2005 |
| Neurocrine Biosciences to Present at the 30th Annual Deutsche Bank Healthcare Conference Posted 4:49 PM PST |
| |
| Thursday, April 14, 2005 |
| Neurocrine Announces Submission of New Drug Application for Indiplon Capsules Posted 5:24 PM PST |
| |
| Monday, April 4, 2005 |
| SAN DIEGO--- Somaxon Pharmaceuticals Appoints Philip Jochelson, M.D., as Sr. Vice President and Chief Medical Officer Posted 5:50 PM PST |
| |
| Neurocrine Biosciences to Present at the CIBC Biotechnology & Specialty Pharmaceuticals Conference Posted 10:04 AM PST |
| |
| Monday, March 14, 2005 |
| Neurocrine Biosciences to Present at the 25th Annual SG Cowen & Company Healthcare Conference Posted 9:13 AM PST |
| |
| Wednesday, March 2, 2005 |
| Neurocrine Biosciences Announces Positive Phase I Results With Its Orally Active GnRH Receptor Antagonist Posted 10:40 AM PST |
| |
| Wednesday, February 16, 2005 |
| Neurocrine Reports Positive Phase III Efficacy and Safety Results With Indiplon Modified Release (MR) Tablets in Treating Adult Patients With Chronic Insomnia Posted 12:32 PM PST |
| |
| Thursday, February 10, 2005 |
| Neurocrine Biosciences Reports Fourth Quarter and Year-End 2004 Results Posted 4:39 PM PST |
| |
| Monday, February 7, 2005 |
| Neurocrine Biosciences Announces Resubmission Status of Indiplon Posted 6:21 PM PST |
| |
| Tuesday, January 11, 2005 |
| Neurocrine Biosciences Announces Plans to Resubmit Indiplon Modified Release New Drug Application (NDA) Posted 4:08 PM PST |
| |
| Monday, January 10, 2005 |
| Neurocrine Biosciences to Present at the 23rd Annual JPMorgan Healthcare Conference Posted 4:39 PM PST |
| |
| Tuesday, December 21, 2004 |
| Indiplon IR NDA (New Drug Application) to Be Reformatted Due to Difficulties in Accessing Portions of the Electronic NDA Posted 9:34 AM PST |
| |
| Thursday, September 9, 2004 |
| Neurocrine Reports Positive Phase III Efficacy and Safety Results With Indiplon Modified Release in Treating Elderly Patients Posted 7:52 AM PST |
| |
| Wednesday, July 28, 2004 |
| Neurocrine Biosciences Reports Second Quarter 2004 Results Posted 5:26 PM PST |
| |
| Monday, July 19, 2004 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2004 Financial Results and Company Update Posted 4:07 PM PST |
| |
| Thursday, July 15, 2004 |
| Neurocrine Reports Progress on Indiplon Registration Posted 9:23 AM PST |
| |
| Wednesday, June 9, 2004 |
| SAN DIEGO--- Neurocrine Biosciences Announces the Appointment of Corinne H. Lyle to its Board of Directors Posted 6:37 PM PST |
| |
| Monday, May 3, 2004 |
| Neurocrine Biosciences Reports First Quarter 2004 Results Posted 7:37 AM PST |
| |
| Thursday, April 22, 2004 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2004 Financial Results Posted 5:34 PM PST |
| |
| Wednesday, April 7, 2004 |
| Neurocrine Reports Two Additional Phase III Trials Demonstrating Indiplon Is Safe and Effective in Treating Elderly Patients With Difficulties Initiating and Maintaining Sleep Posted 8:30 AM PST |
| |
| Wednesday, March 24, 2004 |
| Neurocrine's 'SLEEP' Study Demonstrates Highly Positive Long-Term Efficacy Results With Indiplon Modified Release Posted 9:24 AM PST |
| |
| Tuesday, March 16, 2004 |
| SAN DIEGO--- Neurocrine and Wyeth Satisfy Hart-Scott-Rodino Requirements for the Acquisition of Indiplon Royalty Stream Posted 5:37 PM PST |
| |
| Wednesday, March 3, 2004 |
| Neurocrine Biosciences Presents at the Lehman Brothers Seventh Annual Global Healthcare Conference Posted 8:42 AM PST |
| |
| Tuesday, March 2, 2004 |
| Neurocrine Reports Indiplon Effective in Treating Elderly Patients With Difficulties Maintaining Sleep Posted 9:05 AM PST |
| |
| Monday, March 1, 2004 |
| Neurocrine Reports Positive Results for Indiplon in Adults With Transient Insomnia Posted 8:54 AM PST |
| |
| Thursday, February 26, 2004 |
| SAN DIEGO--- Neurocrine Biosciences Acquires Wyeth's Indiplon Royalty Stream; Deal Said to be around $95 Million Posted 4:31 PM PST |
| |
| Wednesday, February 18, 2004 |
| Neurocrine Reports Positive Results for the First Indiplon Phase III Trial In Elderly Patients With Chronic Insomnia Posted 4:30 PM PST |
| |
| Thursday, January 29, 2004 |
| Neurocrine Biosciences Reports Fourth Quarter and Year-End 2003 Results Posted 5:10 PM PST |
| |
| Monday, January 26, 2004 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2003 Financial Results Posted 6:00 PM PST |
| |
| Tuesday, December 9, 2003 |
| Neurocrine Reports Positive Results for Adult Chronic Insomnia Patients After Middle of the Night Dosing With Indiplon Posted 3:17 PM PST |
| |
| Monday, November 10, 2003 |
| Neurocrine Reports Phase I Clinical Results With Indiplon In Elderly Subjects After Middle of the Night Dosing Posted 4:50 PM PST |
| |
| Monday, November 3, 2003 |
| Neurocrine Biosciences Reports Third Quarter 2003 Results Posted 3:10 PM PST |
| |
| Wednesday, September 24, 2003 |
| Neurocrine Reports Phase III Indiplon Results In Patients With Chronic Insomnia Posted 7:13 PM PST |
| |
| Tuesday, September 23, 2003 |
| Neurocrine Biosciences to Present Phase III Indiplon Modified Release Results for Sleep Maintenance in Patients With Chronic Insomnia at the UBS Global Life Sciences Conference Posted 4:27 PM PST |
| |
| Tuesday, May 20, 2003 |
| Neurocrine Biosciences Announces the First of Two Presentations of indiplon Data at the American Psychiatric Association (APA) Meeting May 17-22 Posted 7:03 AM PST |
| |
| Monday, May 19, 2003 |
| Neurocrine Reports Additional Positive Results From Phase III Chronic Insomnia Trial Posted 7:43 AM PST |
| |
| Tuesday, April 29, 2003 |
| Neurocrine Biosciences Reports First Quarter 2003 Results Posted 5:56 PM PST |
| |
| Monday, April 28, 2003 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2003 Financial Results and Company Update Posted 4:59 PM PST |
| |
| Monday, April 21, 2003 |
| Neurocrine Biosciences Reports Positive Results From Second Phase III Clinical Trial With Indiplon in 200 Patients With Chronic Primary Insomnia Posted 4:11 PM PST |
| |
| Neurocrine Biosciences Announces Webcast and Conference Call Posted 4:09 PM PST |
| |
| Friday, April 11, 2003 |
| Neurocrine Biosciences Announces U.S. Issuance of Polymorph Composition and Method Patent for Its Phase III Insomnia Compound Posted 5:51 PM PST |
| |
| Tuesday, April 8, 2003 |
| SAN DIEGO--- Neurocrine Biosciences Announces the Appointment of Lloyd E. Flanders, Ph.D. to the Position of Senior Vice President of Development Posted 4:59 PM PST |
| |
| Tuesday, February 25, 2003 |
| Neurocrine and Pfizer Satisfy Hart-Scott-Rodino Requirements for Indiplon Collaboration Posted 8:02 AM PST |
| |
| Neurocrine Biosciences Presents at BIO CEO & Investor Conference 2003 Posted 3:03 PM PST |
| |
| Thursday, February 20, 2003 |
| Biosite(R) Announces Collaboration Agreement With Neurocrine Biosciences Posted 8:49 AM PST |
| |
| Tuesday, February 4, 2003 |
| Neurocrine Biosciences Presents at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference Posted 9:00 AM PST |
| |
| Monday, February 3, 2003 |
| Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2002 Financial Results and Company Update Posted 8:10 AM PST |
| |
| Neurocrine Biosciences Reports Fourth Quarter 2002 Results; Company Provides Update On Development Programs Posted 4:24 PM PST |
| |
| Tuesday, January 14, 2003 |
| SAN DIEGO--- SEQUENOM Adds Former Amgen President and COO Harry Hixson to Board of Directors Posted 7:44 AM PST |
| |
| Friday, January 3, 2003 |
| SAN FRANCISCO--- Biotech Survives Its Toughest Year Ever; Despite a Corporate Scandal, Clinical Disappointments, and Product Setbacks, Biotech Still Managed to Raise More Than $10 Billion in 2002 Posted 3:21 PM PST |
| |
